MIA
MIA (MIA SH3 domain containing) is a secreted protein, also known as melanoma-derived growth regulatory protein, CD-RAP or MIA1. It was named for its growth-inhibitory effect on melanoma cells in vitro. Browse Assay Genie's current range of MIA research reagents below, or read on for the biology behind the target.
MIA is a secreted protein whose annotated function is to elicit growth inhibition on melanoma cells in vitro. The same activity has been described for some other neuroectodermal tumours, including gliomas. This activity gave the protein its original name, melanoma inhibitory activity, and its UniProt name, melanoma-derived growth regulatory protein.
The human MIA gene is placed by HGNC in the MIA family and in the group of SH3 domain containing proteins. UniProt assigns the MIA protein to the MIA/OTOR family. Mouse and rat each have an orthologous gene, Mia. The protein is also known by the aliases CD-RAP and MIA1, and the related family member MIA2 has its own entry.
NCBI Gene summarises MIA with predicted annotations from the Alliance of Genome Resources. MIA is predicted to enable growth factor activity and to be involved in extracellular matrix organisation. It is also predicted to act upstream of or within cell-matrix adhesion, and to be located in the extracellular space. These roles are predictions rather than experimentally established functions, so they are best treated as hypotheses when designing experiments.
For researchers, MIA is relevant to work on melanoma and other neuroectodermal tumour biology. It is also relevant to studies of secreted factors that act at the interface between cells and the extracellular matrix.
MIA was identified through its growth-inhibitory activity on melanoma cells in vitro, making it a reference protein in melanoma research.
Growth inhibition by MIA has also been reported for some other neuroectodermal tumours, including gliomas.
MIA is predicted to be involved in extracellular matrix organisation, which makes it a candidate for studies of matrix biology.
MIA is predicted to act upstream of or within cell-matrix adhesion, a process relevant to tumour cell behaviour.
UniProt annotates MIA as eliciting growth inhibition on melanoma cells in vitro, and on some other neuroectodermal tumours such as gliomas. NCBI Gene adds predicted roles in growth factor activity, extracellular matrix organisation and cell-matrix adhesion. It is a secreted protein.
HGNC lists MIA as MIA SH3 domain containing, with the aliases CD-RAP and MIA1. The previous name was melanoma inhibitory activity. UniProt calls the protein melanoma-derived growth regulatory protein. These names all refer to the same gene.
Yes. Mouse and rat both have an ortholog named Mia. In humans, MIA belongs to the MIA/OTOR family, and MIA2 is a related family member. Check the datasheet of any product for its validated reactivity.
MIA2, a related member of the MIA family, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16674; product specifications from Assay Genie datasheets.